TGNA
50
-6
LRCX
37
-9
GT
56
-3
NEM
40
3
DTE
43
5
DGX
48
11
USB
50
-3
KO
38
-3
AN
50
-5
MU
28
-3
STZ
52
-6
WMT
56
-4
HRL
35
-3
GIS
22
-4
MNST
45
-21
PGR
59
-3
FAST
57
-3
C
62
4
PLD
45
-5
XEL
67
2
TGNA
50
-6
LRCX
37
-9
GT
56
-3
NEM
40
3
DTE
43
5
DGX
48
11
USB
50
-3
KO
38
-3
AN
50
-5
MU
28
-3
STZ
52
-6
WMT
56
-4
HRL
35
-3
GIS
22
-4
MNST
45
-21
PGR
59
-3
FAST
57
-3
C
62
4
PLD
45
-5
XEL
67
2
Financhill
Back

Applied Materials Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
33

AMAT
Applied Materials

Last Price:
168.9100
Seasonality Move:
16.23%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
33
Applied Materials (AMAT) is a Sell

Is Applied Materials a Buy, Sell or Hold?

  • The current Applied Materials [AMAT] share price is $168.8800. The Score for AMAT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • AMAT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AMAT Stock Price Chart

What is Applied Materials's stock price today?

  • The Applied Materials share price today is $168.8800
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMAT is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

AMAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.13 Sell
Relative Strength Index (14 RSI): 33.8 Sell
Chaikin Money Flow: -8751079 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (179.188 - 195.368) Sell
Bollinger Bands (100): (181.3159 - 221.0759) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

AMAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 185.81 Sell
20-day SMA: 185.05 Sell
50-day SMA: 190.72 Sell
200-day SMA: 203.95 Sell
8-day EMA: 182.74 Sell
20-day EMA: 186.22 Sell
50-day EMA: 191.17 Sell
200-day EMA: 193.05 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Applied Materials Earnings Growth & AMAT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, an increase next quarter of $0.09 per share, an increase this year of $0.61 per share, and an increase next year of $1.15 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Applied Materials Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):